Intervention

exisulind

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions2

Lead sponsors shown3

Clinical trials

4 shown

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerNCT00078910 · 2003-08-01

Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNCT00052845 · 2002-11-01

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerNCT00041314 · 2002-10-04

Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00041054 · 2002-06-01

Common conditions

Lung Cancer2 Prostate Cancer2

Leading sponsors

Alliance for Clinical Trials in Oncology2 Eastern Cooperative Oncology Group1 National Cancer Institute (NCI)1

Trial status mix

COMPLETED4

Phase mix

PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.